These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6935761)

  • 1. Kinetics in normal humans of anticoagulant activity, radioactivity and lipolytic activity after intravenous administration of (S35) heparin and (S35) heparin fractions.
    De Swart CA; Sixma JJ; Andersson LO; Holmer E; Verschoor L; Nijmeyer A
    Scand J Haematol Suppl; 1980; 36():50-63. PubMed ID: 6935761
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of heparin after a single intravenous or subcutaneous injection].
    Mombelli G; Schaedelin J; Beck EA
    Schweiz Med Wochenschr; 1977 Jun; 107(23):810-5. PubMed ID: 877532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives].
    Millot F; Bara L; Etienne J; Samama M; Laruelle P
    Nouv Rev Fr Hematol (1978); 1987; 29(6):397-400. PubMed ID: 2837726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin fractions with high and low affinities to antithrombin III are cleared at different rates.
    Caranobe C; Petitou M; Dupouy D; Gabaig AM; Sié P; Buchanan MR; Boneu B
    Thromb Res; 1986 Sep; 43(6):635-41. PubMed ID: 3764809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate and anticoagulant activity of tritium labelled heparin in rats.
    Kambayashi J
    Nihon Ketsueki Gakkai Zasshi; 1980 Feb; 43(1):131-44. PubMed ID: 7415766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methylester of palmitic acid as a substrate for the post-heparin lipolytic activity in normal persons and atherosclerotics].
    Skorepa J; Fucík M; Mares P; Novák S
    Sb Lek; 1967; 69(11):316-21. PubMed ID: 6076969
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of various doses and various applications of heparin on the fat metabolism and on blood coagulation.
    Losonczy H; Nagy I
    Wien Klin Wochenschr; 1984 Dec; 96(24):885-9. PubMed ID: 6528619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of heparin administration.
    Perry MO; Horton J
    Arch Surg; 1976 Apr; 111(4):403-9. PubMed ID: 1259578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the anticoagulant effect of heparin.
    Estes JW
    JAMA; 1970 Jun; 212(9):1492-5. PubMed ID: 5467541
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant potency of mucosal and lung heparin.
    McMahon FG; Jain AK; Ryan JR; Lefton TE
    Clin Pharmacol Ther; 1975 Jan; 17(1):79-82. PubMed ID: 1168110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.
    Persson E; Nordenström J; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1987 Apr; 47(2):151-5. PubMed ID: 3576117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant effects of a complex of high molecular weight heparin and arginine.
    Lyapina LA; Obergan TY; Pastorova VE
    Bull Exp Biol Med; 2009 Mar; 147(3):328-30. PubMed ID: 19529854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison at the clinical level of different types and routes of heparin administration.
    Bouvier CA
    Scand J Haematol Suppl; 1980; 36():91-100. PubMed ID: 6935764
    [No Abstract]   [Full Text] [Related]  

  • 14. A rapid procedure for laboratory control of simultaneous treatment with intravenous heparin and oral anticoagulant.
    Nyman D; Wahlberg P
    Acta Med Scand; 1972; 192(1-2):125-8. PubMed ID: 5052388
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation.
    Eckel RH; Goldberg IJ; Steiner L; Yost TJ; Paterniti JR
    Diabetes; 1988 May; 37(5):610-5. PubMed ID: 3360217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant and lipolytic effects of a low molecular weight heparin fraction.
    Harenberg J; Gnasso A; de Vries JX; Zimmermann R; Augustin J
    Thromb Res; 1985 Sep; 39(6):683-92. PubMed ID: 4082106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of very low molecular weight heparin-derived oligosaccharides on lipoprotein lipase release in rabbits.
    Merchant ZM; Erbe EE; Eddy WP; Patel D; Linhardt RJ
    Atherosclerosis; 1986 Nov; 62(2):151-8. PubMed ID: 3801083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of LPL activity after intravenous injection of a low molecular weight heparin.
    Etienne J; Millot F; Pieron R; Laruelle P
    Br J Clin Pharmacol; 1983 Dec; 16(6):712-4. PubMed ID: 6661357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulant, fibrinolytic and antithrombotic effects of the heparin-insulin complex].
    Liapina LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2002; (6):710-3. PubMed ID: 12561334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.